Annovis Bio to Host Patient-Centered Webcast on Key Clinical Developments

Annovis Bio

MALVERN, PA — Annovis Bio, Inc. (NYSE: ANVS) will hold a live webcast aimed at providing patients, caregivers, and families with updates on its clinical trials and future plans. The virtual event, titled Annovis Patients’ Forum: Your Questions Answered, is scheduled for February 27, 2025, at 4:30 PM EST.

The webcast will feature CEO Maria Maccecchini, Ph.D., who will share insights into the company’s ongoing Phase 3 Alzheimer’s disease (AD) trial along with plans for the upcoming Phase 3 Parkinson’s disease (PD) and Open Label Extension studies. The event will begin with a brief presentation highlighting recent milestones, followed by a live Q&A session during which attendees can ask questions directly. To maximize engagement, participants are encouraged to submit their questions ahead of the forum by emailing clinicaltrials@annovisbio.com.

“This event is open to all but is specifically designed for patients, families, and caregivers,” the company stated. “Annovis regularly receives questions from current and prospective patients, and this forum aims to address as many as possible while providing a clear update on our work. Patients are at the heart of our mission, and we remain committed to transparency with our community.”

The company has positioned this forum as part of its broader effort to maintain open communication with its patients and provide clarity about the progress of its clinical programs. Topics to be discussed include the latest advancements in neurological research and Annovis Bio’s strategy for strengthening communication with its patient community.

The forum exemplifies Annovis Bio’s efforts to improve treatment possibilities for conditions like Alzheimer’s and Parkinson’s diseases. By involving patients and their families directly in conversations about clinical progress, the company demonstrates its commitment to transparency and advancing care for those impacted by these challenging neurological disorders.

READ:  Vishay Intertechnology Showcases Cutting-Edge Energy Solutions at ELECRAMA 2025

With this webcast, Annovis Bio solidifies its role as an advocate for patient-centered innovation while continuing its pursuit of groundbreaking treatments. Click here to register.

For the latest news on everything happening in Chester County and the surrounding area, be sure to follow MyChesCo on Google News and MSN.